Key result
Population pharmacokinetic modeling revealed a 57% lower metoprolol clearance rate in geriatric women compared to geriatric men, suggesting that equivalent systemic exposure requires gender-stratified dosing.
Why the study?
Does gender affect the pharmacokinetics of metoprolol in elderly patients, and what are the equivalent doses?
Does gender affect the pharmacokinetics of metoprolol in elderly patients, and what are the equivalent doses?
Gender-stratified dosing of metoprolol (15 mg for geriatric women, 25 mg for geriatric men) is required to achieve equivalent systemic exposure to a 50 mg dose in healthy young males due to a 57% lower clearance rate in elderly women.
Answers are grounded in this paper and cite their sources.
May warrant cautious metoprolol dosing in geriatric women; leaves open prospective validation before practice change.
INTRODUCTION: This article seeks to clarify if gender-based differences occur in the pharmacokinetics of metoprolol in the elderly patients. There are a series of physiologic changes that occur in the elderly ranging from decreased hepatic blood flow to increased adiposity causing higher plasma concentrations at therapeutic doses as compared to the healthy young population. METHODS: Population pharmacokinetic modeling were performed using MONOLIX and Monte-Carlo simulations were conducted using MATLAB. The data was based from a previously published dataset where elderly patients, having multiple comorbidities, were administered a 50mg dose of metoprolol. RESULTS: (CV=23%). CONCLUSION: Gender stratified doses resulting in an equivalent systemic metoprolol exposure in geriatric patients have been identified. Metoprolol doses resulting a similar AUC in a healthy young male administered 50mg tablet were 15mg for geriatric women and 25mg for geriatric men. Further, Metoprolol doses of 25mg for geriatric women and 50mg for geriatric men resulted in an equivalent AUC to a healthy young males dosed with a 100mg tablet. A 15mg Metoprolol tablet may need to be compounded to account for the gender differences in Metoprolol pharmacokinetics.
No takes yet. Share an insight, caveat, or question.
Eugene AR (2016) studied Multiple comorbidities (n=7). Metoprolol vs. Geriatric males (for gender comparison) was evaluated on Apparent Clearance (CL) (57.2% increase in males, p=2.70E-5). Population pharmacokinetic modeling revealed a 57% lower metoprolol clearance rate in geriatric women compared to geriatric men, suggesting that equivalent systemic exposure requires gender-stratified dosing.
Synapse has enriched 10 related papers. Consider them for comparative context: